AFB Q3 2024 Earnings Solid Net Investment Income Amid Stable Municipal Bond Market ACTU Q1 2026 Earnings EPS Miss Weighs on Shares as Biotech Firm Navigates EarlyStage Pipeline Kairos Pharma Ltd KAPA Q1 2026 Earnings EPS Misses Estimates Amid Ongoing ClinicalStage Operations ACTU Q1 2026 Earnings EPS Misses Estimates as Biotech Firm Continues RD Investment UZF Q1 2026 Earnings EPS Surges Past Estimates by 43 ProFrac ACDC Q4 2025 Earnings EPS Miss Deepens as Cost Pressures Offset Operational Gains